tobramycin 0.3 % / dexAMETHasone 0.05 % Ophthalmic Suspension

RxCUI: 849115
RxNorm name: tobramycin 0.3 % / dexAMETHasone 0.05 % Ophthalmic Suspension
Display name: tobramycin 0.3 % / dexAMETHasone 0.05 % Ophthalmic Suspension
Full name: tobramycin 0.3 % / dexAMETHasone 0.05 % Ophthalmic Suspension
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:19

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tobradex ST	TOBRAMYCIN / DEXAMETHASONE	Harrow Eye, LLC	3b99dbb3-ac84-4d0d-b30f-a5db44fdc316	2025-04-01	Warnings, Adverse reactions	Exact identifier rxcui: 849115
Tobradex ST	TOBRAMYCIN / DEXAMETHASONE	Eyevance Pharmaceuticals, LLC	c2d7325e-4f58-5590-e053-2a95a90ace1b	2025-01-16	Warnings, Adverse reactions	Exact identifier rxcui: 849115

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
c2d7325e-4f58-5590-e053-2a95a90ace1b	tobramycin 0.3 % / dexAMETHasone 0.05 % Ophthalmic Suspension	PSN	9	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TOBRADEX ST safely and effectively. See full prescribing information for TOBRADEX ST. TOBRADEX ST (tobramycin and dexamethasone ophthalmic suspension) 0.3%/0.05%, for topical ophthalmic use Initial U.S. Approval: 1988	20250116
c2d7325e-4f58-5590-e053-2a95a90ace1b	dexamethasone 0.5 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension	SCD	9	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TOBRADEX ST safely and effectively. See full prescribing information for TOBRADEX ST. TOBRADEX ST (tobramycin and dexamethasone ophthalmic suspension) 0.3%/0.05%, for topical ophthalmic use Initial U.S. Approval: 1988	20250116
c2d7325e-4f58-5590-e053-2a95a90ace1b	dexamethasone 0.05 % / tobramycin 0.3 % Ophthalmic Suspension	SY	9	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TOBRADEX ST safely and effectively. See full prescribing information for TOBRADEX ST. TOBRADEX ST (tobramycin and dexamethasone ophthalmic suspension) 0.3%/0.05%, for topical ophthalmic use Initial U.S. Approval: 1988	20250116
3b99dbb3-ac84-4d0d-b30f-a5db44fdc316	tobramycin 0.3 % / dexAMETHasone 0.05 % Ophthalmic Suspension	PSN	3	These highlights do not include all the information needed to use TOBRADEX ST safely and effectively. See full prescribing information for TOBRADEX ST. TOBRADEX ® ST (tobramycin and dexamethasone ophthalmic suspension) 0.3%/0.05%, for topical ophthalmic use Initial U.S. Approval: 1988	20250401
3b99dbb3-ac84-4d0d-b30f-a5db44fdc316	dexamethasone 0.5 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension	SCD	3	These highlights do not include all the information needed to use TOBRADEX ST safely and effectively. See full prescribing information for TOBRADEX ST. TOBRADEX ® ST (tobramycin and dexamethasone ophthalmic suspension) 0.3%/0.05%, for topical ophthalmic use Initial U.S. Approval: 1988	20250401
3b99dbb3-ac84-4d0d-b30f-a5db44fdc316	dexamethasone 0.05 % / tobramycin 0.3 % Ophthalmic Suspension	SY	3	These highlights do not include all the information needed to use TOBRADEX ST safely and effectively. See full prescribing information for TOBRADEX ST. TOBRADEX ® ST (tobramycin and dexamethasone ophthalmic suspension) 0.3%/0.05%, for topical ophthalmic use Initial U.S. Approval: 1988	20250401